28 employees
Biofortuna develops a range of molecular diagnostic products using proprietary freeze-dried technology.
2008
$3.3M
from 2 investors over 2 rounds
Biofortuna Ltd raised $3.3M on April 11, 2012
Investors: MSIF
Biofortuna Ltd raised $2M on January 1, 2012